Clinical Trials Browser

Completed × Breast Neoplasms, Male × Fulvestrant × Clear all

NCT00423917 2018-05-08

Fulvestrant and Bevacizumab in Treating Patients With Metastatic Breast Cancer

Phase 2 Completed

36 enrolled 11 charts

Breast Neoplasms, Breast Neoplasms, Male